Combination of azelastine and mometasone for nasal administration

US8318709B2 · kind B2 · utility

Assignee

• Cipla Limited · IN

Inventors

• Amar Lulla · Mumbai, IN
• Geena Malhotra · Jamkhed, IN

Key dates

• Filing date: Jul 23, 2009
• Grant date: Nov 27, 2012
• Expiry date: Jul 23, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.